{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:02:23Z","timestamp":1761541343775},"reference-count":47,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Phys."],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1002\/mp.12156","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T19:32:41Z","timestamp":1487014361000},"page":"1257-1267","source":"Crossref","is-referenced-by-count":8,"title":["Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients"],"prefix":"10.1002","volume":"44","author":[{"given":"Hendrik","family":"Westendorp","sequence":"first","affiliation":[{"name":"Department of Medical Physics, Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carel J.","family":"Hoekstra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos J.","family":"Immerzeel","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine M.G.","family":"van de Pol","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles G.H.J.","family":"Ni\u00ebl","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.J.","family":"Kattevilder","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonnis T.","family":"Nuver","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 W.","family":"Minken","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Department of Radiation Oncology; Radiotherapiegroep behandellocatie Deventer; Nico Bolkesteinlaan 85 7416 SE Deventer The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinus A.","family":"Moerland","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Department of Radiation Oncology; University Medical Center Utrecht; Heidelberglaan 100 3584 CX Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"10.1002\/mp.12156-BIB0001|mp12156-cit-0001","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0360-3016(03)01448-2","article-title":"125I versus 103 Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial","volume":"57","author":"Wallner","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0002|mp12156-cit-0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2009.01.050","article-title":"Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of Leeds 10-year single-center brachytherapy experience","volume":"76","author":"Henry","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0003|mp12156-cit-0003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0004|mp12156-cit-0004","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ijrobp.2007.05.002","article-title":"Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes","volume":"69","author":"Stone","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0005|mp12156-cit-0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0006|mp12156-cit-0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0007|mp12156-cit-0007","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1118\/1.3246613","article-title":"AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of task group 137","volume":"36","author":"Nath","year":"2009","journal-title":"Med Phys."},{"key":"10.1002\/mp.12156-BIB0008|mp12156-cit-0008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American brachytherapy society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0009|mp12156-cit-0009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clon.2015.03.004","article-title":"The effect of dose and quality assurance in early prostate cancer treated with low dose rate brachytherapy as monotherapy","volume":"27","author":"Henry","year":"2015","journal-title":"Clin Oncol."},{"key":"10.1002\/mp.12156-BIB0010|mp12156-cit-0010","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2009.03.031","article-title":"Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0011|mp12156-cit-0011","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2006.09.010","article-title":"Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation","volume":"67","author":"Orio","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0012|mp12156-cit-0012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2008.09.008","article-title":"Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150","volume":"91","author":"Vordermark","year":"2009","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0013|mp12156-cit-0013","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0014|mp12156-cit-0014","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0360-3016(02)04279-7","article-title":"Dysuria after permanent prostate brachytherapy","volume":"55","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0015|mp12156-cit-0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00066-006-1530-z","article-title":"Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parameters","volume":"182","author":"Pinkawa","year":"2006","journal-title":"Strahlenther Onkol."},{"key":"10.1002\/mp.12156-BIB0016|mp12156-cit-0016","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0167-8140(12)72166-7","article-title":"V150 predicts erectile outcome in patients undergoing low-dose-rate (LDR) brachytherapy alone for prostate cancer","volume":"103","author":"Kollmeier","year":"2012","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0017|mp12156-cit-0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.radonc.2009.12.012","article-title":"Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy","volume":"94","author":"Polo","year":"2010","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0018|mp12156-cit-0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2010.02.012","article-title":"Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome","volume":"96","author":"Hinnen","year":"2010","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0019|mp12156-cit-0019","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brachy.2007.08.005","article-title":"Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry","volume":"6","author":"Westendorp","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0020|mp12156-cit-0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2016.04.015","article-title":"Edema and seed displacements affect intraoperative permanent prostate brachytherapy dosimetry","volume":"96","author":"Westendorp","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0021|mp12156-cit-0021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM task group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys."},{"key":"10.1002\/mp.12156-BIB0022|mp12156-cit-0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brachy.2012.03.007","article-title":"Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy","volume":"12","author":"Bowes","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0023|mp12156-cit-0023","doi-asserted-by":"publisher","first-page":"S1538","DOI":"10.1016\/j.brachy.2016.11.018","article-title":"Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for 125I prostate brachytherapy","author":"Peters","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0024|mp12156-cit-0024","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2010.04.038","article-title":"10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients","volume":"80","author":"Crook","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0025|mp12156-cit-0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2009.04.002","article-title":"Correlation between pre- and postimplant dosimetry for iodine-125seed implants for localized prostate cancer","volume":"75","author":"Al-Qaisieh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0026|mp12156-cit-0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brachy.2014.08.044","article-title":"Dosimetric evaluation of clinical target volume in the postimplant analysis of low-dose-rate brachytherapy for prostate cancer","volume":"14","author":"Nasser","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0027|mp12156-cit-0027","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ijrobp.2006.02.003","article-title":"Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?","volume":"65","author":"Potters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0028|mp12156-cit-0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2007.07.002","article-title":"Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications","volume":"84","author":"Zelefsky","year":"2007","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0029|mp12156-cit-0029","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brachy.2009.09.007","article-title":"Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy","volume":"9","author":"Ishiyama","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0030|mp12156-cit-0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2008.09.013","article-title":"Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants","volume":"91","author":"Moerland","year":"2009","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0031|mp12156-cit-0031","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brachy.2014.09.012","article-title":"Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment","volume":"14","author":"Shaikh","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0032|mp12156-cit-0032","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brachy.2014.11.011","article-title":"Refining prostate seed brachytherapy: comparing high-, intermediate-, and low-activity seeds for I-125 permanent seed prostate brachytherapy","volume":"14","author":"Delouya","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0033|mp12156-cit-0033","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.brachy.2013.04.003","article-title":"Regional treatment margins for prostate brachytherapy","volume":"12","author":"Jastaniyah","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0034|mp12156-cit-0034","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1017\/S1460396912000283","article-title":"The dosimetric impact of supplementing pre-planned prostate implants with discretionary 125 I seeds","volume":"12","author":"McParland","year":"2013","journal-title":"J Radiother Pract."},{"key":"10.1002\/mp.12156-BIB0035|mp12156-cit-0035","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.brachy.2014.12.004","article-title":"Regional dose metrics as predictors of biochemical failure and local recurrence after low-doserate prostate brachytherapy","volume":"14","author":"Spadinger","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0036|mp12156-cit-0036","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0360-3016(98)00434-9","article-title":"Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated?","volume":"43","author":"D\u2019Amico","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0037|mp12156-cit-0037","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2007.02.041","article-title":"Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy","volume":"52","author":"Merrick","year":"2007","journal-title":"Eur Urol"},{"key":"10.1002\/mp.12156-BIB0038|mp12156-cit-0038","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.juro.2013.02.021","article-title":"Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy","volume":"190","author":"Bittner","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/mp.12156-BIB0039|mp12156-cit-0039","doi-asserted-by":"crossref","first-page":"N391","DOI":"10.1088\/0031-9155\/60\/20\/N391","article-title":"An automated, fast and accurate registration method to link stranded seeds in permanent prostate implants","volume":"60","author":"Westendorp","year":"2015","journal-title":"Phys Med Biol."},{"key":"10.1002\/mp.12156-BIB0040|mp12156-cit-0040","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ijrobp.2006.11.027","article-title":"Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR","volume":"67","author":"Smith","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1002\/mp.12156-BIB0041|mp12156-cit-0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2017.01.010","article-title":"Dosimetric impact of contouring and image registration variability on dynamic 125I prostate brachytherapy","author":"Westendorp","year":"2017","journal-title":"Brachytherapy."},{"key":"10.1002\/mp.12156-BIB0042|mp12156-cit-0042","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.urology.2010.01.067","article-title":"Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer","volume":"76","author":"Zelefsky","year":"2010","journal-title":"Urol"},{"key":"10.1002\/mp.12156-BIB0043|mp12156-cit-0043","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5114\/jcb.2016.57817","article-title":"Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUS","volume":"8","author":"Ishiyama","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1002\/mp.12156-BIB0044|mp12156-cit-0044","doi-asserted-by":"crossref","first-page":"091712","DOI":"10.1118\/1.4893761","article-title":"An image-guidance system for dynamic dose calculation in prostate brachytherapy using ultrasound and fluoroscopy","volume":"41","author":"Kuo","year":"2014","journal-title":"Med Phys."},{"key":"10.1002\/mp.12156-BIB0045|mp12156-cit-0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.2011.10825.x","article-title":"Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer","volume":"109","author":"Langley","year":"2012","journal-title":"BJU Int."},{"key":"10.1002\/mp.12156-BIB0046|mp12156-cit-0046","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.radonc.2015.05.015","article-title":"Re-distribution of brachytherapy dose using a differential dose prescription adapted to risk of local failure in low-risk prostate cancer patients","volume":"115","author":"Rylander","year":"2015","journal-title":"Radiother Oncol."},{"key":"10.1002\/mp.12156-BIB0047|mp12156-cit-0047","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ijrobp.2015.02.043","article-title":"Dosimetry modeling for focal low-dose-rate prostate brachytherapy","volume":"92","author":"Al-Qaisieh","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmp.12156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mp.12156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T15:43:55Z","timestamp":1625413435000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mp.12156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1002\/mp.12156","archive":["Portico"],"relation":{},"ISSN":["0094-2405"],"issn-type":[{"value":"0094-2405","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,22]]}}}